FDA approves first treatment for non-cystic fibrosis bronchiectasis First DPP1 inhibitor drug milestone marks a long-awaited breakthrough for NCFB patients.

https://www.drugdiscoverynews.com/fda-approves-first-treatment-for-non-cystic-fibrosis-bronchiectasis-16571